Publications (57) ELIXABET LÓPEZ LÓPEZ publications

2024

  1. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  2. LncRNA expression and regulatory networks across pediatric cancers

    Translational Pediatrics

  3. Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study

    British Journal of Haematology

2023

  1. Genetics and Epigenetics in Complex Diseases

    International Journal of Molecular Sciences

  2. LncRNA-en adierazpen aldakorrak haurren leuzemia linfoblastiko akutuan dituen inplikazioak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 43, pp. 191-207

  3. The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review

    Cancers, Vol. 15, Núm. 19

  4. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study

    Pediatric Blood and Cancer, Vol. 69, Núm. 6

  2. Hypersensitivity to Pegylated E.colia sparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group

    European Journal of Cancer, Vol. 162, pp. 65-75

  3. MicroRNA-based therapeutic strategies for cancer

    MicroRNA: From Bench to Bedside (Elsevier), pp. 503-520

  4. lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review

    International journal of oncology, Vol. 60, Núm. 5

2021

  1. A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer’s Disease

    Molecular Neurobiology, Vol. 58, Núm. 1, pp. 55-64

  2. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 161

  3. Meduloblastoma pediatrikoaren pronostikorako markatzaile molekularren identifikazioa

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 40, pp. 51-76

  4. New insights into methotrexate accumulation in leukemia cells in vivo

    Molecular and Cellular Oncology

  5. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 165

  6. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia

    The Lancet Haematology, Vol. 8, Núm. 7, pp. e513-e523

  7. Systematic review of pharmacogenetic factors that influence high-dose methotrexate pharmacokinetics in pediatric malignancies

    Cancers, Vol. 13, Núm. 11

  8. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma

    Critical Reviews in Oncology/Hematology, Vol. 159

2020

  1. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia

    Nature cancer, Vol. 1, Núm. 3, pp. 329-344